Corporate History

 

Founding of Corporate Entities
1948HAMA Research Institute (closed)
1951HAMA Research Institute, Sakai facility (closed)
1952HAMA Research Institute renamed as Hamari Chemicals, Ltd.
1955Hamari Chemicals, Ltd., Tokyo Office
1961Hamari Chemicals, Ltd., Takatsuki facility (closed)
1974Hamari Company, Limited (“Hamari Health”)
1975Hamari Chemicals, Ltd., Kunijima facility
1980Yonezawa Hamari Chemicals, Ltd.
2005Hamari Chemicals USA Inc.
2008Kobe Research Center (closed)
2011Hamari Chemicals USA Inc. San Diego Research Center (closed)
2012Chitose Hamari Chemicals, Ltd.
2020Hamari Chemicals, Ltd. head office relocated
Kobe and Hamari research centers relocated to head office
2021Chitose Hamari Chemicals, Ltd, and Yonezawa Hamari Chemicals, Ltd. merged to HAMARI PFST, Ltd.
2023HAMARI Group reorganized under HAMARI Holdings Corp.

 

Historical Active Ingredients
1968first peptide at commercial scale: Glycylgycyl
1984first US patent: Diltiazem
1985first US (FDA) approved Active Pharmaceutical Ingredient: Ibuprofen
2002first US (FDA) approved New Dietary Ingredient: Zinc Carnosine
2006first Russia (MHSDRF) approved API: Benfotiamine
2010first Ukraine (MHU) approved API: Benfotiamine
2012first India (DCGI) approved API: Benfotiamine
2015first Australia (TGA) approved Complementary Medicine: Zinc Carnosine

 

Featured Facility Improvements
2008established high-potency lab and kilo-lab, Osaka facility
2015established automated warehouse, Yonezawa facility
established high-potency lab, Chitose facility
2019established high-potency manufacture plant, Yonezawa facility

 

Awards
2003Yamagata Prefecture Environmental Protection Award, Yonezawa facility
2013Kansai Quality Award Winner, Improvement Award, Hamari HQ
2015Kansai Quality Award Winner, Award for Excellence, Hamari HQ
2019Kansai Quality Award Winner, Gold Award, Hamari HQ

 

Certifications
2001ISO 14001 Certification, Yonezawa facility
2011Kosher Certification, Yonezawa facility
2013ISO 14001 Certification, Chitose facility
2015Marketing Authorization Holder (PMDA, Type 1 and 2), Japan

 

Corporate Programs
19925S activity, Yonezawa facility
19955S activity, Osaka facility
2005Corporate Identity Campaign
2009Group QA Program
20155S activity, Chitose facility